“In the next 5-10 years, pharmacogenomics will revolutionize medicine and the way in which drugs are developed” – Global Business Insight
By identifying differences between patients’ genetic makeup and the effect this has on drug response, pharmacogenomics has the potential to reduce medical costs, improve drug development and therapy and cause a shift from treatment to prevention.
It is not surprising then, “that many leading industry figures believe pharmacogenomics will revolutionize the face of pharmaceutical drug development and, consequently, clinical practice”.
Pharmacogenomics and Drug Therapy:
Selection of appropriate drug and dose for the individual patient in order to:
- Achieve optimal therapeutic response
- Avoid therapeutic failure
- Minimize side effects and toxicity
The value of the metabolic validation tool, via pharmacogenomic testing, is to predict and select right drug, right dose for the right person. Making patient care more effective and improving quality of life.
For more information on pharmacogenomics, contact:
PGx Medical
Individualized Care – Personalized Medicine
405-509-5112
info@pgxmed.com
Source:
oecd.org
AAPS.org